Blog: Top Health Technology Trends to Watch in 2023
As the calendar turns on another year, the state of health tech continues on an exciting trajectory. Despite a 2022 that was marred by economic downturn and tech related pullbacks, digital health investments still produced over $15B in funding.
Blog: Why Click-and-Mortar is the Future of Healthcare
As healthcare delivery methods continue to evolve in the post COVID-19 climate, providers are well accustomed to delivering virtual care to their patients. Since the pandemic began and forced clinicians and patients to interact remotely, nearly all providers and most patients in need have experienced care delivery via telemedicine.
Blog: The Story of PRO-SYNC: Why Everyone Needs Brain Performance Technology
In 2015, I was first introduced to a military grade prototype of EYE-SYNC. Prior to that, I had read little and heard even less about the clinical utility of eye movement assessments in acute conditions such as concussion. However, when I develop an insatiable curiosity about something novel (and potentially game changing) I become relentless […]
Blog: Taking EYE-SYNC Across the Pond: The CE Mark Significance
Last week, we announced a significant milestone in the global mission of our company, one that will allow us to commercialize EYE-SYNC into the 27 countries that make up the European Union (EU).
Blog: The Clinical Utility of Objective Convergence Measures in Concussion Assessment
This month, we’ll be introducing our newest concussion product feature, the objective convergence measurement. This assessment paradigm features automated measures of both eyes as they follow a target as it moves from distance to the Near Point of Convergence and back to the start position.
Blog: Digital Health and CNS Trials: A Promising Future Together
Much has been written and discussed about the impact that Digital Health is having on the evolution of clinical trials. While many agree that the COVID pandemic has greatly accelerated this process, others are split on the long-term impact Digital Health technologies project to ultimately have on patient outcomes.
Blog: The Provider Dilemma – Accelerating Digital Health Technology Adoption
While the pandemic is often credited with the accelerated adoption of digital health technologies among healthcare systems, particularly over the past two years, the competition among these organizations remains in its infancy.
Blog: The Five Ways Augmented Reality (AR) will Disrupt the Care of Vestibular Disorders
Dizziness related disorders are one of the most common forms of disability impacting quality of life today. Prevalent more among adults as they advance in age, dizziness has become one of the most commons type of chronic disabilities, affecting between 9-11% of the population.
Blog: EYE-SYNC and the Pico Neo 3 Pro Eye: Advancing VR for Healthcare
This month, we’ll be launching the newest integrated Virtual Reality (VR) headset from our partners at Pico Interactive, the Neo 3 Pro Eye.
Blog: The Consumerization of Digital Health
As technological innovation continues to outpace the evolution of healthcare practices, a fundamental shift is occurring. Patient centered care is no longer, having been replaced by consumer directed care. Consumers have shifted away from reactionary “sick” care options, opting to instead gravitate towards technology to monitor their own health and wellness.
Blog: 2021 – A Year In Review
For many of us, 2021 can be summed up in just a few words.
Unpredictable. Scary. Chaotic. Promising. Hopeful.
Whatever your preference, it is likely we can agree that these uncertain times has forced all of us to think outside the box, to adapt to changing circumstances, and to learn new things and to do them in unique ways. We at SyncThink…
Blog: A Message From Our Founder
Our recent FDA clearance allowing EYE-SYNC as an aide to concussion diagnosis is a major milestone for diagnostic eye-tracking technology and its use in measuring prediction, a key brain function. SyncThink has spent decades studying this through rigorous clinical research, in order for patients and clinicians to benefit from the use of reliable, objective data to identify prediction related deficits, which are often discovered for the first time.